Rome, March 17 (AdnKronos Health) – A crystallographic infrared tube, mounted on a tripod camera. It was 1965, and the following year gimmick that would evolve into Senographe device, which is the first mammography machine in history. It’s been exactly 50 years since the Compagnie Générale de Radiologie (CGR) of Paris has made the diagnostic equipment has become a cornerstone of medicine, then further developed innovation after innovation: GE Healthcare, the medical division of General Electric, will acquire Cgr in 1987 , and products for mammography after Senographe systems “are still the standard for breast cancer screening,” recalls the company.
The very future of breast health has been one of the European Radiology Congress themes (ECR) 2016. In early March in Vienna presented the latest news for a first-line technology in the fight against a disease which today is estimated to affect one in eight women during their lifetime, although survival rates are the highest ever, and growing. Mammography is in fact the examination of breast tissue that uses X-rays to help detect lesions or calcifications that may indicate the presence of a breast cancer, allowing doctors to identify problem areas as soon as possible and to define a plan of therapy.
In 1965 the French Charles Gros radiologist to ask the Parisian Cgr to find a way to develop a dedicated device for breast imaging X-ray, which could have provided better images than those obtained with equipment conventional. “The first system for mammography was produced towards the end of 1965: it was just a crystallographic infrared tube, mounted on a tripod camera. In 1966 he became the original Senographe, the first dedicated mammography breast”, he explained Remy Klausz, chief engineer at the division Detection and Guidance Solutions from GE Healthcare.
In the next 50 years, to drive improvements in technology and design in mammography have been new discoveries on exposure to X-rays, on compression techniques and breast tissue details, such as density, but also the desire to improve the experience of patients undergoing examination. Aurelie Boudier, Global Creative Director of Brand and Design Language in the Global Design Center of GE Healthcare Buc, near Paris, and its predecessors have played a leading role in many of these developments. From Senographe tomosynthesis, since 1970 the Global Design Center has worked closely with the design team to develop some of the most innovative solutions for women around the world, making an important contribution to the history of mammography.
The underlying technology of mammography has evolved in parallel with the needs of women subjected to screening. In the beginning the attention was focused on the need to make women aware of the risk of cancer, and raise awareness about the benefits of routine screening. Now that scientists know more about breast cancer and women know more about mammography, there is a growing attention to the issue of women’s emancipation. “Over the past decade, we have really seen a change in the behavior of patients,” noted Boudier. “They participate more and want to actively manage their own health. If a woman has a positive experience, if his fears are taken into account and if the examination procedure is made as pleasant as possible, will spread a positive message in his acquaintances, and above all it will undergo screening again when and if necessary. ”
The future, according to experts, will be in the sign of the digital innovations: “Women want more and more involved and have more control over their health,” concluded Boudier. “Every digital device that allows a woman to prepare for the exam or to relax during the latter, will be of great help and will play a central role in the relationship between patient and radiologist. In this way you could really create an environment in which the patient may develop a more positive towards the management of their health. ”
No comments:
Post a Comment